SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on January 6, 2009. The filing reports the consolidated financial results for the second quarter of fiscal year 2009, ended November 30, 2008. Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as Landec Corporation.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not detail specific material changes versus the prior comparable period. It only confirms the issuance of a press release announcing the results for the quarter ended November 30, 2008.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. Such information is presumed to be in the referenced Exhibit 99.1 press release.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended November 30, 2008, by reviewing Exhibit 99.1 (Press Release).
- Confirm the company name discrepancy between the request metadata (Lifecore Biomedical) and the filing (Landec Corporation).
- Review the full press release for any forward-looking statements or risk factors not summarized in this 8-K.